国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
18期
2253-2255
,共3页
黄宇%龙伟东%陈朝阳%林土坤
黃宇%龍偉東%陳朝暘%林土坤
황우%룡위동%진조양%림토곤
氢氯吡格雷%辛伐他汀%急性冠脉综合征
氫氯吡格雷%辛伐他汀%急性冠脈綜閤徵
경록필격뢰%신벌타정%급성관맥종합정
Clopidogrel%Simvastatin%Acute coronary syndrome
目的 探讨氢氯吡格雷与辛伐他汀联合治疗急性冠脉综合征(ACS)的临床效果.方法 将2007年1月-2009年5月间在我院治疗的ACS患者64例随机分为观察组和对照组,对照组给予常规治疗措施,观察组同时给予氢氯吡格雷与辛伐他汀联合治疗措施.结果 两组患者血小板聚集率比较:治疗后观察组患者血小板聚集率为(39.26±2.21)%,对照组血小板聚集率为(43.78±2.23)%,观察组患者血小板聚集率明显低于对照组,两组比较差异具有显著性(P<0.05).观察组心绞痛复发12例(35.29%),再住院8例(23.52%),明显低于对照组的24例(70.59%)、17例(50.00%),两组比较差异具有显著性(P<0.05),且对照组有1例中风患者.观察组出现恶心呕吐1例,对照组出现恶心呕吐2例,无其他明显副作用.结论 氢氯吡格雷与辛伐他汀联合治疗急性冠脉综合征效果确切,值得应用.
目的 探討氫氯吡格雷與辛伐他汀聯閤治療急性冠脈綜閤徵(ACS)的臨床效果.方法 將2007年1月-2009年5月間在我院治療的ACS患者64例隨機分為觀察組和對照組,對照組給予常規治療措施,觀察組同時給予氫氯吡格雷與辛伐他汀聯閤治療措施.結果 兩組患者血小闆聚集率比較:治療後觀察組患者血小闆聚集率為(39.26±2.21)%,對照組血小闆聚集率為(43.78±2.23)%,觀察組患者血小闆聚集率明顯低于對照組,兩組比較差異具有顯著性(P<0.05).觀察組心絞痛複髮12例(35.29%),再住院8例(23.52%),明顯低于對照組的24例(70.59%)、17例(50.00%),兩組比較差異具有顯著性(P<0.05),且對照組有1例中風患者.觀察組齣現噁心嘔吐1例,對照組齣現噁心嘔吐2例,無其他明顯副作用.結論 氫氯吡格雷與辛伐他汀聯閤治療急性冠脈綜閤徵效果確切,值得應用.
목적 탐토경록필격뢰여신벌타정연합치료급성관맥종합정(ACS)적림상효과.방법 장2007년1월-2009년5월간재아원치료적ACS환자64례수궤분위관찰조화대조조,대조조급여상규치료조시,관찰조동시급여경록필격뢰여신벌타정연합치료조시.결과 량조환자혈소판취집솔비교:치료후관찰조환자혈소판취집솔위(39.26±2.21)%,대조조혈소판취집솔위(43.78±2.23)%,관찰조환자혈소판취집솔명현저우대조조,량조비교차이구유현저성(P<0.05).관찰조심교통복발12례(35.29%),재주원8례(23.52%),명현저우대조조적24례(70.59%)、17례(50.00%),량조비교차이구유현저성(P<0.05),차대조조유1례중풍환자.관찰조출현악심구토1례,대조조출현악심구토2례,무기타명현부작용.결론 경록필격뢰여신벌타정연합치료급성관맥종합정효과학절,치득응용.
Objective To explore the efficacy of clopidogrel combined with simvastatin for acute coronary syndrome (ACS). Methods 64 patients with ACS in our hospital from January 2007 to May 2009 were randomly assigned to receive conventional therapies (control group) or combination therapy with clopidogrel and simvastatin (study group). Results The decrease in hs-CRP level was markedly greater in the study group than in the control group (P<0.05). The reduction in blood lipids did not differ significantly between the two groups (P>0.05). The rates of platelet aggregation,recurrence of angina pectoris,and rehospitalization were significantly lower in the study group than in the control group (P<0.05 for all comparisons). No obvious adverse reactions were found in the two groups. Conclusions Combination therapy with clopidogrel and simvastatin is effective in the treatment of acute coronary syndrome.